Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.